Partial Wave Spectroscopic Detection of Colon Cancer Risk (Brushings)
|ClinicalTrials.gov Identifier: NCT01095432|
Recruitment Status : Completed
First Posted : March 30, 2010
Last Update Posted : May 23, 2016
|Condition or disease||Intervention/treatment|
|Ulcerative Colitis Colon Cancer||Procedure: PWS Testing|
|Study Type :||Observational|
|Actual Enrollment :||40 participants|
|Official Title:||Partial Wave Spectroscopic Detection of Colon Cancer Risk|
|Study Start Date :||March 2010|
|Actual Primary Completion Date :||November 2015|
|Actual Study Completion Date :||November 2015|
Main Study Group
All subjects who are undergoing a standard of care colonoscopy for flexible sigmoidoscopy and have a history of UC and agree to participate will be in the main study group.
Procedure: PWS Testing
Partial wave spectroscopy (PWS)has been developed to allow scientists to learn about any changes to the cells that may indicate a risk of developing colon cancer.
- Study samples of rectal mucosa (the moist lining of the rectum) using PWS. [ Time Frame: 1 year ]Samples will be collected and then shipped to Northwestern University for analysis using PWS. This is to assess accuracy of detecting the risk for colon cancer.
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01095432
|United States, Illinois|
|University of Chicago, DCAM|
|Chicago, Illinois, United States, 60637|
|Principal Investigator:||David T Rubin, MD||University of Chicago|